Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Stanford study finds new way to improve seizure treatment
Researchers at the Stanford University School of Medicine discovered that the drug valproic acid (VPA), which is marketed by Abbott under the brand name Depakote, boosts the amount
Researchers at the Stanford University School of Medicine discovered that the drug valproic acid (VPA), which is marketed by Abbott under the brand name Depakote, boosts the amount
NBTY will purchase the stock of Zila Nutraceuticals, which manufacturers and markets the Ester-C nutritional supplement brand, for approximately $40 million in cash, including up to a $3
The phase I clinical trial was conducted in healthy volunteers to evaluate specific pharmacokinetic and absorption behavior of the drug compound once it is in the gastrointestinal tract.
The field test will provide the investigators with the crucial information needed to launch a phase III trial of the needle-free vaccine. The placebo-controlled study is designed to
Results from the trial, which are published in the peer-reviewed journal Clinical Infectious Diseases, show that cold sores treated with SoloVir healed on average approximately a day and
In a study, of more than 2,300 African-American and Caucasian women with and without breast cancer, the researchers found that among breast-cancer cases overall, 2.4% and 2.3% carried
The companies have also entered into a separate deal concerning certain women’s health products. Under the Adderall XR agreement Barr will not be allowed to market its generic
The ascending-dose, double-blind, randomized, placebo-controlled study will examine the safety and tolerability profile of DG051 as well as pharmacokinetics and pharmacodynamics. “This work is built on our pioneering
The extended approval is based on one-year data from a double-blind, placebo-controlled trial named IMPACT 2 and two-year data from a double-blind, placebo-controlled trial named IMPACT. Findings from
Teva has begun selling 25mg, 50mg and 100mg sertraline tablets in the US. As the first company to file an abbreviated new drug application (ANDA) containing a paragraph